Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer

BACKGROUND: Proteinuria is the most frequent adverse event of lenvatinib use. However, the association between lenvatinib-induced proteinuria and renal dysfunction remains unclear. METHODS: We retrospectively reviewed medical records of patients with thyroid cancer without proteinuria treated with l...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibutani, Yuma, Suzuki, Shinya, Sagara, Atsunobu, Enokida, Tomohiro, Okano, Susumu, Fujisawa, Takao, Sato, Fumiaki, Yumoto, Tetsuro, Sano, Motohiko, Kawasaki, Toshikatsu, Tahara, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043443/
https://www.ncbi.nlm.nih.gov/pubmed/36998435
http://dx.doi.org/10.3389/fonc.2023.1154771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043443/
https://www.ncbi.nlm.nih.gov/pubmed/36998435
http://dx.doi.org/10.3389/fonc.2023.1154771

Ejemplares similares